404 related articles for article (PubMed ID: 11602641)
1. Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase.
Ehrt S; Schnappinger D; Bekiranov S; Drenkow J; Shi S; Gingeras TR; Gaasterland T; Schoolnik G; Nathan C
J Exp Med; 2001 Oct; 194(8):1123-40. PubMed ID: 11602641
[TBL] [Abstract][Full Text] [Related]
2. Expression of many immunologically important genes in Mycobacterium tuberculosis-infected macrophages is independent of both TLR2 and TLR4 but dependent on IFN-alphabeta receptor and STAT1.
Shi S; Blumenthal A; Hickey CM; Gandotra S; Levy D; Ehrt S
J Immunol; 2005 Sep; 175(5):3318-28. PubMed ID: 16116224
[TBL] [Abstract][Full Text] [Related]
3. Viperin inhibits interferon-γ production to promote Mycobacterium tuberculosis survival by disrupting TBK1-IKKε-IRF3-axis and JAK-STAT signaling.
Liang Y; Liang Y; Wang Q; Li Q; Huang Y; Li R; Pan X; Lie L; Xu H; Han Z; Liu H; Wen Q; Zhou C; Ma L; Zhou X
Inflamm Res; 2024 Jun; 73(6):897-913. PubMed ID: 38625657
[TBL] [Abstract][Full Text] [Related]
4. Type I IFN Inhibits Alternative Macrophage Activation during Mycobacterium tuberculosis Infection and Leads to Enhanced Protection in the Absence of IFN-γ Signaling.
Moreira-Teixeira L; Sousa J; McNab FW; Torrado E; Cardoso F; Machado H; Castro F; Cardoso V; Gaifem J; Wu X; Appelberg R; Castro AG; O'Garra A; Saraiva M
J Immunol; 2016 Dec; 197(12):4714-4726. PubMed ID: 27849167
[TBL] [Abstract][Full Text] [Related]
5. Prolonged toll-like receptor signaling by Mycobacterium tuberculosis and its 19-kilodalton lipoprotein inhibits gamma interferon-induced regulation of selected genes in macrophages.
Pai RK; Pennini ME; Tobian AA; Canaday DH; Boom WH; Harding CV
Infect Immun; 2004 Nov; 72(11):6603-14. PubMed ID: 15501793
[TBL] [Abstract][Full Text] [Related]
6. Immune control of tuberculosis by IFN-gamma-inducible LRG-47.
MacMicking JD; Taylor GA; McKinney JD
Science; 2003 Oct; 302(5645):654-9. PubMed ID: 14576437
[TBL] [Abstract][Full Text] [Related]
7. Lactic acid bacteria enhance autophagic ability of mononuclear phagocytes by increasing Th1 autophagy-promoting cytokine (IFN-gamma) and nitric oxide (NO) levels and reducing Th2 autophagy-restraining cytokines (IL-4 and IL-13) in response to Mycobacterium tuberculosis antigen.
Ghadimi D; de Vrese M; Heller KJ; Schrezenmeir J
Int Immunopharmacol; 2010 Jun; 10(6):694-706. PubMed ID: 20381647
[TBL] [Abstract][Full Text] [Related]
8. Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and -independent mechanisms.
Fortune SM; Solache A; Jaeger A; Hill PJ; Belisle JT; Bloom BR; Rubin EJ; Ernst JD
J Immunol; 2004 May; 172(10):6272-80. PubMed ID: 15128816
[TBL] [Abstract][Full Text] [Related]
9. Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo: the roles of macrophages, endogenous IFN-gamma, and TNF receptor-1-mediated signaling.
Salkowski CA; Detore G; McNally R; van Rooijen N; Vogel SN
J Immunol; 1997 Jan; 158(2):905-12. PubMed ID: 8993010
[TBL] [Abstract][Full Text] [Related]
10. Cooperation between reactive oxygen and nitrogen intermediates in killing of Rhodococcus equi by activated macrophages.
Darrah PA; Hondalus MK; Chen Q; Ischiropoulos H; Mosser DM
Infect Immun; 2000 Jun; 68(6):3587-93. PubMed ID: 10816516
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro.
Vazquez-Torres A; Jones-Carson J; Mastroeni P; Ischiropoulos H; Fang FC
J Exp Med; 2000 Jul; 192(2):227-36. PubMed ID: 10899909
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-4-mediated inhibition of nitric oxide production in interferon-gamma-treated and virus-infected macrophages.
Paludan SR; Ellermann-Eriksen S; Lovmand J; Mogensen SC
Scand J Immunol; 1999 Feb; 49(2):169-76. PubMed ID: 10075021
[TBL] [Abstract][Full Text] [Related]
13. Nitric Oxide Modulates Macrophage Responses to
Braverman J; Stanley SA
J Immunol; 2017 Sep; 199(5):1805-1816. PubMed ID: 28754681
[TBL] [Abstract][Full Text] [Related]
14. Restricted cytosolic growth of Francisella tularensis subsp. tularensis by IFN-gamma activation of macrophages.
Edwards JA; Rockx-Brouwer D; Nair V; Celli J
Microbiology (Reading); 2010 Feb; 156(Pt 2):327-339. PubMed ID: 19926654
[TBL] [Abstract][Full Text] [Related]
15. The timing of TNF and IFN-gamma signaling affects macrophage activation strategies during Mycobacterium tuberculosis infection.
Ray JC; Wang J; Chan J; Kirschner DE
J Theor Biol; 2008 May; 252(1):24-38. PubMed ID: 18321531
[TBL] [Abstract][Full Text] [Related]
16. Novel role for calcium-independent phospholipase A(2) in the macrophage antiviral response of inducible nitric-oxide synthase expression.
Maggi LB; Moran JM; Scarim AL; Ford DA; Yoon JW; McHowat J; Buller RM; Corbett JA
J Biol Chem; 2002 Oct; 277(41):38449-55. PubMed ID: 12167650
[TBL] [Abstract][Full Text] [Related]
17. Evidence for dispensability of protein kinase R in host control of tuberculosis.
Mundhra S; Bryk R; Hawryluk N; Zhang T; Jiang X; Nathan CF
Eur J Immunol; 2018 Apr; 48(4):612-620. PubMed ID: 29436711
[TBL] [Abstract][Full Text] [Related]
18. Interferon-γ, tumor necrosis factor, and interleukin-18 cooperate to control growth of Mycobacterium tuberculosis in human macrophages.
Robinson CM; Jung JY; Nau GJ
Cytokine; 2012 Oct; 60(1):233-41. PubMed ID: 22749533
[TBL] [Abstract][Full Text] [Related]
19. Induction of in vitro human macrophage anti-Mycobacterium tuberculosis activity: requirement for IFN-gamma and primed lymphocytes.
Bonecini-Almeida MG; Chitale S; Boutsikakis I; Geng J; Doo H; He S; Ho JL
J Immunol; 1998 May; 160(9):4490-9. PubMed ID: 9574555
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion.
Pai RK; Convery M; Hamilton TA; Boom WH; Harding CV
J Immunol; 2003 Jul; 171(1):175-84. PubMed ID: 12816996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
